Clover Biopharmaceuticals gets a $2 billion valuation on the hopes of a Delta-effective vaccine Read More
Related Articles
It’s the New Year, and pharma companies are already hiking prices for popular drugs
Posted on Author admin
Birthing a drug isn’t easy. It’s an intensive, unpredictable, and enormously stressful endeavor which can dash the hopes of the world’s greatest scientific minds and the patients they seek to serve. Initial clinical trial victories can quickly swerve into cataclysmic failures. But that reality, and the unique nature of the pharmaceutical industry’s life-changing mission, gets […]
As the climate crisis deepens, it’s time to focus on adaptation
Posted on Author admin
Mitigating climate collapse is the obvious priority, but adaptation is also inevitable. Read More
Social media’s latest test: policing misinformation about Russia’s Ukraine invasion
Posted on Author admin
YouTube, Facebook, and Twitter will face scrutiny over their response to Russian propaganda. Read More